Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Crohn's & Colitis Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9338
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crohn’s & Colitis Foundation Inc (CCF) is a non-profit organization that provides treatments for crohn’s disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. It provides clinical research services, clinical trial services and paediatric clinical trial services. CCF supports ongoing research initiatives and clinical studies to encourage cooperation among investigators, research centers, and other resources. The organization works in collaboration with healthcare providers and caregivers to deliver education, awareness and support services through patient-centric education and advocacy programs to patients suffering from inflammatory bowel diseases. It partners include European Federation of Crohn’s and Ulcerative Colitis Associations, International Organization of Inflammatory Bowel Disease (IOIBD) and International Ostomy Association. CCF is headquartered in New York, the US.

Crohn’s & Colitis Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Merger 12
Broad Foundations To Merge With Crohn’s & Colitis Foundation 12
Crohn’s & Colitis Foundation Inc – Key Employees 13
Crohn’s & Colitis Foundation Inc – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Oct 30, 2017: Crohn’s & Colitis Foundation Receives $5 Million to Fund Innovative Translational and Clinical IBD Research 15
Sep 11, 2017: Scientists Construct First Predictive Model of Inflammatory Bowel Disease 16
Other Significant Developments 17
Apr 11, 2018: The Crohn’s & Colitis Foundation Selects Diversigen as a Preferred Provider for Metagenomics and Microbiome Analysis Services 17
Feb 12, 2018: Crohn’s & Colitis Foundation Expands Patient-Powered Research Network 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn's & Colitis Foundation Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Broad Foundations To Merge With Crohn's & Colitis Foundation 12
Crohn's & Colitis Foundation Inc, Key Employees 13

List of Figures
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Domino Printing Sciences plc:企業の戦略的SWOT分析
    Domino Printing Sciences plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Treatt Plc:企業の戦略・SWOT・財務分析
    Treatt Plc - Strategy, SWOT and Corporate Finance Report Summary Treatt Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Binding Site Group Ltd:企業の製品パイプライン分析2018
    Summary The Binding Site Group Ltd (Binding Site) is a clinical diagnostic tools supplier that concentrates on research, development, manufacturing and distribution of immunodiagnostic assays. The company provides product portfolio such as antibodies, antigens, bulk antisera, assays for plasma prote …
  • Intuit Inc.:企業の戦略・SWOT・財務情報
    Intuit Inc. - Strategy, SWOT and Corporate Finance Report Summary Intuit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Baker & McKenzie LLP:企業の戦略的SWOT分析
    Baker & McKenzie LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Navios Maritime Holdings Inc.:企業のM&A・事業提携・投資動向
    Navios Maritime Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Cantabio Pharmaceuticals Inc (CTBO):企業の財務・戦略的SWOT分析
    Summary Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, …
  • Avara Pharmaceutical Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical in …
  • Gran Tierra Energy Inc. (GTE)-石油・ガス分野:企業M&A・提携分析
    Summary Gran Tierra Energy Inc. (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia; and also owns …
  • Reckitt Benckiser Group plc:企業のM&A・事業提携・投資動向
    Reckitt Benckiser Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reckitt Benckiser Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Collins Foods Ltd (CKF):企業の財務・戦略的SWOT分析
    Collins Foods Ltd (CKF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Strategic Metals Ltd (SMD):企業の財務・戦略的SWOT分析
    Summary Strategic Metals Ltd (Strategic Metals) is a mining and mineral exploration company that acquires, explores, produces, and develops gold properties across Canada. Its portfolio covers a broad suite of metals, including gold, silver, lead, zinc, copper, tin, tungsten, vanadium and lithium. It …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Companhia Energetica de Minas Gerais SA:発電所・企業SWOT分析
    Companhia Energetica de Minas Gerais SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Helijet International Inc.:企業の戦略・SWOT・財務情報
    Helijet International Inc. - Strategy, SWOT and Corporate Finance Report Summary Helijet International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Public Service Enterprise Group Inc (PEG)-エネルギー分野:企業M&A・提携分析
    Summary Public Service Enterprise Group Inc. (PSEG) is a diversified energy holding company that generates, transmits and distributes electricity, and gas. It supplies electricity from its nuclear, fossil and renewable energy assets as part of its wholesale energy activities. The company sells elect …
  • Minnkota Power Cooperative Inc:発電所・企業SWOT分析
    Minnkota Power Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Haci Omer Sabanci Holding A.S. (SAHOL):企業の財務・戦略的SWOT分析
    Haci Omer Sabanci Holding A.S. (SAHOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • GI Dynamics Inc (GID):医療機器:M&Aディール及び事業提携情報
    Summary GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic …
  • Myelin Repair Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Myelin Repair Foundation (MRF) is a medical research organization that discovers and develops myelin repair therapeutics for multiple sclerosis. The organization publishes various peer-reviewed scientific articles, identifies different myelin repair treatment targets and discovers multiple r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆